Abstract:Polyploid giant cancer cells (PGCCs) are key contributors to cancer heterogeneity, and the formation of PGCCs is associated with changes in the expression of cell-cycle-related proteins. This study investigated the intracellular localization and expression level of multiple cell-cycle-related proteins in PGCCs derived from BT-549 and HEY cells. In addition, the formation of PGCCs and the clinicopathological significance of cell-cycle-related proteins in human breast and ovarian cancer were examined. The expression levels of cell-cycle-related proteins, including cyclin B1, CDC25B, CDC25C, and other cell cycle phosphoproteins, including Chk2, and Aurora-A kinase, were determined using immunostaining and western blotting both in vitro and in vivo. Migration, invasion, and proliferation in control cells, cyclin B1 knockdown cells and their PGCCs following CoCl2 treatment were compared. In addition, human breast and ovarian cancer samples were collected to determine the correlation of number of PGCCs, expression of cell-cycle-related proteins, and tumor pathologic grade and metastasis. Our results confirm that cyclin B1 was localized in the cytoplasm of PGCCs and in the nuclei of their budding daughter cells. The phosphorylated proteins Chk2 and Aurora-A kinase regulated the expression and subcellular localization of cyclin B1, CDC25B, and CDC25C. The rate of positive cytoplasmic staining of cyclin B1 and positive nuclear staining of both CDC25B and CDC25C increased with increase in tumor grade and lymph node metastasis. Cell-cycle-related proteins, including cyclin B1, CDC25B, and CDC25C play an important role in regulating the formation of PGCCs. The inhibition of cyclinB1 and CoCl2 treatment significantly promoted cell proliferation, invasion, and migration abilities. The subcellular localization of these cell-cycle-related proteins was regulated by other cell cycle phosphoproteins, and was associated with pathologic grade and metastasis of tumors in cases of human breast and ovarian cancer.

Regulation of Cyclin E and Cancers

Down-regulation of Cyclin E Expression by Caffeine Promotes Cancer Cell Entry into the S-phase of the Cell Cycle.

Promotive Effect of Decreased Cyclin E Threshold on Cell Proliferation

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

Cyclin E in normal physiology and disease states

Ubiquitin ligases: cell-cycle control and cancer

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

The Requirement for Cyclin E in C-Myc Overexpressing Breast Cancers.

Cyclin-dependent Kinase 9 Promotes Cervical Cancer Development Via AKT2/p53 Pathway.

Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

Targeting low molecular weight cyclin E (LMW-E) in breast cancer

[Expression of Cyclin D1 and P27kip1 in Renal Cell Carcinoma and Its Significance].

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer

The subcellular location of cyclin B1 and CDC25 associated with the formation of polyploid giant cancer cells and their clinicopathological significance

CYCLINS AND CELL CYCLE CHECKPOINTS

Clinical and Laboratory Studies of Expression of Cyclin A in Leukemia Cells.

The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

Slower CDK4 and faster CDK2 activation in the cell cycle

The double dealing of cyclin D1

Overexpression of Cyclin B1 in Human Esophageal Squamous Cell Carcinoma Cells Induces Tumor Cell Invasive Growth and Metastasis.